Enrique Espinosa Selected Research

Enrique Espinosa Research Topics

Disease

38	Neoplasms (Cancer) 09/2023 - 09/2004
25	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2005
24	Melanoma (Melanoma, Malignant) 05/2024 - 03/2009
8	Triple Negative Breast Neoplasms 12/2023 - 04/2013
8	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2006
7	Carcinoma (Carcinomatosis) 01/2020 - 12/2002
6	Infections 11/2016 - 02/2006
5	HIV Infections (HIV Infection) 06/2021 - 02/2006
4	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 09/2012
3	Uveal melanoma 11/2022 - 01/2021
3	Diarrhea 01/2022 - 06/2018
3	Immune Reconstitution Inflammatory Syndrome 06/2021 - 06/2011
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 11/2010
2	Weight Loss (Weight Reduction) 12/2021 - 03/2021
2	Fatigue 06/2020 - 01/2015
2	Disease Progression 01/2018 - 12/2010
2	Ovarian Neoplasms (Ovarian Cancer) 03/2015 - 01/2008
2	Pneumonia (Pneumonitis) 01/2014 - 11/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2012 - 11/2009
2	Lung Neoplasms (Lung Cancer) 11/2009 - 04/2004
1	Leiomyosarcoma 12/2023
1	Sarcoma (Soft Tissue Sarcoma) 12/2023
1	Synovial Sarcoma (Synovioma) 12/2023
1	Retinoblastoma (Glioblastoma, Retinal) 01/2023
1	Cardiotoxicity 02/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Febrile Neutropenia 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 12/2023 - 05/2009
13	ParaffinIBA 09/2023 - 01/2008
12	Proteins (Proteins, Gene)FDA Link 09/2023 - 12/2005
9	Formaldehyde (Formol)FDA Link 01/2022 - 01/2008
5	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2017
5	VemurafenibIBA 12/2021 - 04/2014
5	Bevacizumab (Avastin)FDA Link 04/2016 - 11/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 04/2016 - 01/2008
4	Immune Checkpoint InhibitorsIBA 12/2023 - 11/2021
4	ProteomeIBA 01/2023 - 12/2005
4	Hormones (Hormone)IBA 01/2023 - 04/2013
4	IpilimumabIBA 01/2021 - 12/2014
4	Estrogen ReceptorsIBA 11/2017 - 06/2015
4	CytokinesIBA 05/2014 - 12/2010
3	taxaneIBA 12/2023 - 01/2014
3	Dacarbazine (DIC)FDA LinkGeneric 12/2023 - 04/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2023 - 06/2020
3	RNA (Ribonucleic Acid)IBA 09/2023 - 05/2010
3	Docetaxel (Taxotere)FDA Link 01/2022 - 04/2012
3	Peptides (Polypeptides)IBA 11/2021 - 11/2009
3	NivolumabIBA 01/2021 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2015
3	InterferonsIBA 06/2018 - 12/2010
2	130-nm albumin-bound paclitaxelIBA 12/2023 - 11/2017
2	dabrafenibIBA 10/2023 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2015
2	AntibodiesIBA 01/2023 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 10/2019
2	tebentafuspIBA 11/2022 - 11/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022 - 11/2021
2	Trastuzumab (Herceptin)FDA Link 02/2022 - 01/2014
2	Phosphotransferases (Kinase)IBA 11/2021 - 01/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2013
2	Androgen Receptors (Androgen Receptor)IBA 06/2019 - 01/2019
2	Sunitinib (Sutent)FDA Link 06/2018 - 11/2010
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 12/2002
2	ErbB Receptors (EGF Receptor)IBA 11/2017 - 01/2017
2	Taxoids (Taxanes)IBA 11/2017 - 07/2013
2	Proto-Oncogene Proteins B-rafIBA 01/2017 - 04/2014
2	Messenger RNA (mRNA)IBA 11/2016 - 11/2008
2	Carboplatin (JM8)FDA LinkGeneric 03/2015 - 01/2008
2	Immunomodulating AgentsIBA 01/2015 - 11/2011
2	Fluorouracil (Carac)FDA LinkGeneric 07/2013 - 12/2002
2	ChemokinesIBA 04/2013 - 11/2011
1	ipatasertibIBA 12/2023
1	atezolizumabIBA 12/2023
1	pazopanib FDA Link 12/2023
1	Gemcitabine FDA Link 12/2023
1	Ifosfamide FDA LinkGeneric 12/2023
1	trametinibIBA 10/2023
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023
1	acylcarnitineIBA 01/2023
1	palbociclibIBA 01/2023
1	Retinoblastoma ProteinIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	SuspensionsIBA 01/2022
1	CreatinineIBA 12/2021
1	Serum AlbuminIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 12/2021
1	cobimetinibIBA 12/2021
1	Glycoproteins (Glycoprotein)IBA 11/2021

Therapy/Procedure

30	Therapeutics 12/2023 - 09/2004
14	Drug Therapy (Chemotherapy) 09/2023 - 03/2009
7	Immunotherapy 05/2024 - 01/2015
5	Neoadjuvant Therapy 01/2023 - 11/2017
3	Adjuvant Chemotherapy 01/2017 - 04/2004
2	Combination Drug Therapy (Combination Chemotherapy) 03/2021 - 04/2013
2	Highly Active Antiretroviral Therapy (HAART) 02/2006 - 04/2005
1	Treatment Delay 01/2022
1	Activities of Daily Living (ADL) 12/2021
1	Art Therapy 06/2021